Menu
中文Book a checkup
Chung Shan Hospital (Taipei) · Taipei · District hospital

Advanced MRI Whole-Body Health Checkup - Plan D

US$1,713
NT$55,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Chung Shan Hospital on (02)2708-1166 ext. 7378, 7376 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A premium-tier program with Whole-body MRI, Abdominal ultrasound, Pelvic (gynecologic) ultrasound, Bone density (DXA) and Creatine kinase and a 55-test panel, with a doctor's review at the end.

Takes
One day, no overnight
Lead time
7 days
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Whole-body MRI

Broad tumor survey of the whole body without radiation.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Pelvic (gynecologic) ultrasound

Uterus and ovary abnormalities (fibroids, cysts).

Bone density (DXA)

Osteoporosis and fracture risk.

Every test, in English

55 tests listed, 53 of them on our shared test list, so they line up against other hospitals' packages.

Vitals4
Blood Count2
Liver Function11
Kidney & Electrolytes5
Lipids & Cardiometabolic5
Glucose2
Thyroid & Endocrine2
Tumor Markers5
Infection Serology4
Urine & Stool1
Cardiac3
X-ray2
Ultrasound2
MRI Imaging1
Men's Health1
Bone & Body Composition1
Eye1
Consultation1
Show all 55 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Blood type (ABO/Rh)Your blood group.
Complete blood countAnemia, infection and blood cell disorders.
Liver Function
AlbuminLiver function and nutrition status.
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AmylasePancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.
AST (SGOT)Liver cell damage.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Globulin and A/G ratioImmune protein levels.
Lactate dehydrogenaseNon-specific tissue damage marker.
Total bilirubinJaundice, liver and bile problems.
Total proteinNutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CalciumBone, parathyroid and kidney conditions.
CreatinineKidney function.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
High-sensitivity CRPInflammation linked to heart disease risk.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
T3Thyroid hormone level.
TSHThyroid function; the primary thyroid screening test.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Ovarian cancer marker.
CA 15-3Breast cancer marker.
CEAColorectal and other GI cancer marker.
PSAProstate cancer marker.
Infection Serology
Hepatitis A antibodyImmunity to hepatitis A.
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Cardiac
Creatine kinaseMuscle and heart muscle damage.
EchocardiogramHeart structure, valves and pumping function.
Resting ECGHeart rhythm and signs of prior heart damage.
X-ray
Abdominal X-ray (KUB)Kidney stones and bowel abnormalities.
Chest X-rayLung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
MRI Imaging
Whole-body MRIBroad tumor survey of the whole body without radiation.
Men's Health
Digital rectal examProstate and rectal abnormalities.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Eye
Visual acuityVision sharpness.
Consultation
Physician consultation and report reviewA doctor explains your results and what to do next.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Blood type (ABO/Rh)
Your blood group.
Complete blood count
Anemia, infection and blood cell disorders.
Liver Function
Albumin
Liver function and nutrition status.
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
Amylase
Pancreatic or salivary gland enzyme; elevated levels can indicate pancreatitis.
AST (SGOT)
Liver cell damage.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Globulin and A/G ratio
Immune protein levels.
Lactate dehydrogenase
Non-specific tissue damage marker.
Total bilirubin
Jaundice, liver and bile problems.
Total protein
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Calcium
Bone, parathyroid and kidney conditions.
Creatinine
Kidney function.
Electrolytes (Na, K, Cl)
Salt and fluid balance; kidney and hormone problems.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
High-sensitivity CRP
Inflammation linked to heart disease risk.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
T3
Thyroid hormone level.
TSH
Thyroid function; the primary thyroid screening test.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125
Ovarian cancer marker.
CA 15-3
Breast cancer marker.
CEA
Colorectal and other GI cancer marker.
PSA
Prostate cancer marker.
Infection Serology
Hepatitis A antibody
Immunity to hepatitis A.
Hepatitis B surface antibody
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Cardiac
Creatine kinase
Muscle and heart muscle damage.
Echocardiogram
Heart structure, valves and pumping function.
Resting ECG
Heart rhythm and signs of prior heart damage.
X-ray
Abdominal X-ray (KUB)
Kidney stones and bowel abnormalities.
Chest X-ray
Lung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
MRI Imaging
Whole-body MRI
Broad tumor survey of the whole body without radiation.
Men's Health
Digital rectal exam
Prostate and rectal abnormalities.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Eye
Visual acuity
Vision sharpness.
Consultation
Physician consultation and report review
A doctor explains your results and what to do next.
Also listed: Lung cancer screening (SCC antigen), T4 (thyroxine). And 1 further item the hospital lists only in Chinese.

Before you book

Booking lead time7 days
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Chung Shan Hospital (Taipei)
District hospital
Taipei · Daan

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

8 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment

  • The center does not accept credit card payment for checkups.

    Source ↗ · checked 2026-09-20

  • Checkup patients are asked to check in at the Health Management Center at 8:30 in the morning.

    Source ↗ · checked 2026-09-20

  • The center asks patients to book their checkup at least one week in advance.

    Source ↗ · checked 2026-09-20

  • Patients who want to cancel or reschedule are asked to notify the center at least 3 days before the scheduled checkup date.

    Source ↗ · checked 2026-09-20

Before and on the day

  • Patients are asked to bring their regular daily medication and may take it once the checkup portion is finished.

    Source ↗ · checked 2026-09-20

  • Patients need to provide a urine sample on the morning of the checkup.

    Source ↗ · checked 2026-09-20

Ask your own doctor before changing any medicine.

Results

  • The center says checkup results take 2 to 4 working days.

    Source ↗ · checked 2026-09-20

  • The written report is sent by expedited mail in about two weeks, or can be collected at a follow-up visit.

    Source ↗ · checked 2026-09-20

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
EBV VCA-IgAas listed: EBV IgA (nasopharyngeal cancer marker)
US$22
NT$700
Exercise stress ECGas listed: Treadmill exercise ECG
US$56
NT$1,800
Carotid ultrasound
US$62
NT$2,000
Breast ultrasound
US$62
NT$2,000
For women
Low-dose chest CTas listed: Low-dose chest CT (no contrast)
US$187
NT$6,000
No contrast agent used
Head CT
US$187
NT$6,000
Sigmoidoscopyas listed: Sigmoidoscopy (hemorrhoids, polyps, tumors, rectal/sigmoid disease)
US$72
NT$2,300
Gastroscopy (upper GI endoscopy)as listed: Gastroscopy (esophagus, stomach, duodenum)
US$125
NT$4,000
Colonoscopyas listed: Colonoscopy (hemorrhoids, polyps, tumors, rectal/sigmoid/colon disease)
US$143
NT$4,600
Mammography
US$75
NT$2,400
For women

Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$3,724–6,068 for a woman (49 of 51 tests) and US$3,463–5,817 for a man (47 of 50 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 0.8 mSv from the tests we could identify, a typical adult dose for these exams: roughly 4 months of natural background radiation (about 3 mSv a year, US average).

This package also lists 3 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Abdominal X-ray (KUB) · about 0.7 mSv
  • Bone density (DXA) · about less than 0.01 mSv
  • Chest X-ray · about 0.1 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 17 of these tests
Hepatitis C antibody
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Blood pressure
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Bone density (DXA)
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
CA-125
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Fasting glucose
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hemoglobin A1c
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Hepatitis B surface antigen
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
HDL cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Height, weight and BMI
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
High-sensitivity CRP
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
Pelvic (gynecologic) ultrasound
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
PSA
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Resting ECG
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Total cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
TSH
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Urinalysis
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Visual acuity
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 9 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Whole-body MRI

Guidelines on eating and drinking vary by center. Remove jewelry and metal, and expect to lie still for an extended time.

Mention when booking: Mention a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Advanced MRI Whole-Body Health Checkup - Plan D
US$1,713
Book this checkup

If this isn't quite right

Same hospital, cheaper
Advanced MRI Whole-Body Health Checkup - Plan C
Chung Shan Hospital (Taipei)
US$1,402
Same focus, Taoyuan
One-Day PET Guardian Type
Taoyuan Chang Gung Memorial Hospital Health Examination Center
US$1,698

Other packages at Chung Shan Hospital

PackageTestsPrice
Whole-Body Health Checkup (NT$5,000 Plan)31
US$156
NT$5,000
Whole-Body Health Checkup (NT$7,000 Plan)37
US$218
NT$7,000
Whole-Body Health Checkup (NT$15,000/16,000 Plan)58
US$467
NT$15,000
Women US$498
Advanced CT (Computed Tomography) Health Checkup57
US$935
NT$30,000
Advanced MRI Whole-Body Health Checkup - Plan A55
US$935
NT$30,000
Advanced MRI Whole-Body Health Checkup - Plan B55
US$1,121
NT$36,000
Advanced MRI Whole-Body Health Checkup - Plan C54
US$1,402
NT$45,000

All packages at Chung Shan Hospital (Taipei) →

Similar packages in Taipei

Same tier, other hospitals in Taipei, closest in price first.
PackageHospitalTestsPrice
Deluxe Cardiovascular PackageChang Gung Memorial Hospital Taipei Health Examination Center74
US$1,713
NT$55,000
Men US$1,776
Brain-Heart-Lung PackageKoo Foundation Sun Yat-Sen Cancer Center45
US$1,720
NT$55,200
Enhanced Whole-Body MRI Cancer-Screening Checkup PackageCheng Hsin General Hospital Health Management Center29
US$1,620
NT$52,000
Women from US$1,682
+20% without Taiwan ID or NHI card
IMS-4 CheckupMackay Memorial Hospital Health Examination Center64
US$1,807
NT$58,000
Women's PackageKoo Foundation Sun Yat-Sen Cancer Center54
US$1,515
NT$48,620
Senior Cardiac Checkup PackageCheng Hsin General Hospital Health Management Center52
US$1,433
NT$46,000
+20% without Taiwan ID or NHI card

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Brain · Cancer screening · Heart and blood vessels · Lung · All checkups in Taipei · What a checkup costs in Taiwan